Literature DB >> 21389705

Paediatric Baha.

Ann-Louise McDermott, Patrick Sheehan.   

Abstract

Bone-anchored hearing aids (Baha(®)) are a well-established and readily available option for aural rehabilitation for children. Audiological outcomes and paediatric quality of life results have added to the evidence of benefit of Baha. Recent years have seen an increase in the number of centres worldwide providing a Baha service for children. Indications for Baha have evolved. The paediatric population present a variety of challenges for clinicians who undertake Baha surgery. Complex medical conditions, social and educational issues, and trauma are such examples. The surgical techniques are now varied and the timing of surgery varies between surgeons and Baha centres. Fortunately, serious complications are very rare, and to date there are no more than six significant such case reports in the literature. Careful patient selection and a multidisciplinary team approach with an understanding of the problems that present in children should result in a successful outcome for the child.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21389705     DOI: 10.1159/000323580

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  3 in total

Review 1.  Diseases of the middle ear in childhood.

Authors:  Amir Minovi; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

2.  Speech understanding with a new implant technology: a comparative study with a new nonskin penetrating Baha system.

Authors:  Anja Kurz; Mark Flynn; Marco Caversaccio; Martin Kompis
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

3.  Pediatric morphometric study to guide the optimized implantation of the Osia® 2 implant system.

Authors:  Balint Posta; Adam Perenyi; Linda Szabo; Roland Nagy; Gabor Katona; Zsuzsanna Csakanyi; Laszlo Rovo; Zsofia Bere
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-16       Impact factor: 3.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.